Striving to Make Advances in Lung Cancer Research

For over 30 years, Gilead has studied medicines for life-threatening diseases like lung cancer.  With multiple clinical trials in non-small cell lung cancer (NSCLC), we are striving to innovate with next-generation therapies, combinations, and technologies as we seek to deliver improved outcomes and provide hope for people living with lung cancer.

Lung Hero Banner

Our Mission is to Support Your Journey


In 2023, it’s estimated that there will be nearly 238,000 new cases of lung cancer in the United States.

A lung cancer diagnosis can feel isolating, but remember, you are not alone. There are clinical trial options available that may play a role in your lung cancer journey.

What we are studying?

Non-Small Cell Lung Cancer

  • Non-small cell lung cancer (NSCLC) is cancer of the cells that line the surface of the lung airways.
  • NSCLC includes squamous cell carcinoma, large cell carcinoma, and adenocarcinoma, among others.
  • Over 80% of lung cancer cases are NSCLC.
  • 83% of diagnoses are in people age 65 or older, and 53% are age 70 or older.

Small Cell Lung Cancer

  • Small cell lung cancer (SCLC) includes small cell carcinoma (oat cell cancer) and combined small cell carcinoma.
  • SCLC is the most aggressive form of lung cancer. Approximately 15% of lung cancer diagnoses are SCLC.
  • In 60% of SCLC cases, the cancer has spread before it is diagnosed.
  • SCLC is slightly more common in women than men, and most diagnoses occur between age 75 to 79.

Active Trials, Not Recruiting

The Lung Cancer Community

Our partnerships with lung cancer advocacy organizations committed to change

Partnership with LungCAN

Lung Cancer Action Network members collaborate on strategic projects to increase their collective impact and serve those at risk for or living with lung cancer more efficiently and effectively. Lung Cancer Action Network cultivates a cooperative environment, encourages the exchange of ideas, fosters effectiveness, and efficiency, and gives member organizations a united voice behind a shared cause. Lung Cancer Action Network honors and respects each member organization's brand, personality, and unique mission.

Lung Cancer Community

Advocacy Groups

Organizations committed to research, education, awareness, and support for the lung cancer community

Your Questions Answered

We're working to discover, develop and deliver innovative therapeutics for people with life-threatening diseases.


We're working to discover, develop and deliver innovative therapeutics for people with life-threatening diseases.

All trials have different timelines due to various factors, such as the trial phase, study design, treatment duration or health condition being studied. During the consent process before enrolling, the research team will explain the specifics about the trial.
Due to the many differences in insurance plans across the country, coverage in clinical trials can vary. You will learn more about your options during pre-screening.
If you don’t qualify due to not meeting the trial criteria, you should check with your healthcare provider to seek other options.
If you are living with a medical condition, joining a clinical trial may give you access to a new potential treatment before it is publicly available. Just as importantly, it can help researchers understand how this potential treatment affects the body and increase their knowledge about the disease and how to treat it. Participation can also play a vital role in helping others who have a similar condition, both now and in the future. Healthy volunteers in trials contribute to this medical progress as well by helping understand the effect of the potential treatment and any safety concerns.
As with all medical records, participant privacy and confidentiality in trials are protected by law. Once consent is signed, you will be given a trial code. Your trial records will not include your name or personal identity but will identify you with a trial code. This code can only be tracked back to you via a code key which is held by the responsible physician. Your name or personal identity will never be disclosed.
Yes, participants are volunteers and may withdraw from a clinical trial at any time.
A placebo is an inactive version of an intervention that is not intended to provide any medical benefit. It is designed to look the same as the active intervention, so the participant and research team do not know it is a placebo. The placebo is used by comparison to confirm any effects of the intervention being studied, if no approved intervention is available.
"Standard of care" is an intervention already approved for a specific health condition that is available publicly. Interventions in a clinical trial are still being tested to ensure safety and effectiveness.
Some clinical trials are designed to be "double blind" so both participants and researchers are unaware of which treatment group participants are assigned to. This prevents bias from affecting clinical trial data.
Your informed consent is required before being enrolled in a trial. This means you have been provided all relevant information about the study design, how you will participate, your right to withdraw at any time, study alternatives, your personal data protection and the associated risks and benefits. Informed consent is designed to protect patient safety and privacy.
Under FDA regulations, an Institutional Review Board (IRB) is a group that has been formally designated to review and monitor research at a hospital or institution involving human participants. In accordance with FDA regulations, an IRB has the authority to approve, require modifications in, or disapprove research.
Participants are always welcome to visit their usual healthcare providers during a trial. Sometimes, it is important for healthcare providers to collaborate with the research team to ensure success.
After your participation ends, the study may continue for months or years. Once final results from all participants are compiled and analyzed, they are often published publicly. Clinical study report (CSR) synopses and plain language summaries (PLSs) may be made available for certain studies. Check with your clinical trial site or send an email to [email protected] to learn more.
There are a wide variety of professionals involved with any clinical trial, all of whom are vital to ensuring safety and success. The principal investigator, or PI, leads the trial and directs the team of doctors, nurses and other healthcare workers. The clinical trial coordinator manages day-to-day activities and is the main contact for participants. Many clinical trials also have an independent Data and Safety Monitoring Board (DSMB) who periodically reviews data to ensure participant safety, and sometimes effectiveness.